All lobbying filings

PORTERFIELD, FETTIG & SEARS, LLC

PORTERFIELD, FETTIG & SEARS, LLC filed a Q1 termination report for TAKEDA PHARMACEUTICALS AMERICA, INC. on April 20, 2026, reporting $30,000 in lobbying income.

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceuticals

All filings by PORTERFIELD, FETTIG & SEARS, LLC · Everything TAKEDA PHARMACEUTICALS AMERICA, INC. has reported

Filing · LD-2 quarterly report Q1 termination

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Illinois

Representation ended

Mar 1, 2026

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

General issues related to drug research and innovation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.